Order Entry
ContactUsLinkComponent
Human Recombinant PARP1 (from Insect Cells (Sf9))
Human Recombinant PARP1 (from Insect Cells (Sf9))
Catalog #: 89144-026
Supplier:  Enzo Life Sciences
CAS Number:  
Human Recombinant PARP1 (from Insect Cells (Sf9))
Catalog #: 89144-026
Supplier:  Enzo Life Sciences
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.

Specifications

  • Protein/peptide type:
    Recombinant
  • Source:
    Insect cells (Sf9)
  • Species:
    Human
  • Size:
    20 µg
  • Biological activity:
    ≥600U/mg protein. One unit is defined as the amount of enzyme that synthesizes 1nmol of poly(ADP-ribose) per min. at 25°C, pH 7.5.
  • Protein/peptide name:
    PARP1
  • Purity:
    >99% (SDS-PAGE)
  • Concentration:
    1mg/ml
  • Formulation:
    Liquid. In 100mM TRIS-HCl, pH 7.5, containing 14mM β-mercaptoethanol, 0.5mM EDTA, 0.5mM PMSF and 10% glycerol.
  • Grade:
    High purity
  • Purification:
    Affinity purified.
  • Cat. no.:
    89144-026
  • Supplier No.:
    201-063-C020

Specifications

About this item

Produced in Sf9 cells.

Customers Who Bought This Also Bought